KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Bausch Health Companies (BHC) Long-Term Debt Issuances (2017 - 2025)

Bausch Health Companies' Long-Term Debt Issuances history spans 15 years, with the latest figure at $133.0 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances fell 73.72% year-over-year to $133.0 million; the TTM value through Dec 2025 reached $10.6 billion, up 1496.67%, while the annual FY2025 figure was $10.6 billion, 1496.67% up from the prior year.
  • Long-Term Debt Issuances for Q4 2025 was $133.0 million at Bausch Health Companies, up from -$1.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $10.4 billion in Q2 2025 and bottomed at -$3.0 million in Q1 2021.
  • The 5-year median for Long-Term Debt Issuances is $161.0 million (2022), against an average of $1.2 billion.
  • The largest annual shift saw Long-Term Debt Issuances plummeted 200.0% in 2021 before it skyrocketed 32966.67% in 2022.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $524.0 million in 2021, then crashed by 32.25% to $355.0 million in 2022, then tumbled by 58.87% to $146.0 million in 2023, then soared by 246.58% to $506.0 million in 2024, then tumbled by 73.72% to $133.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Long-Term Debt Issuances are $133.0 million (Q4 2025), -$1.0 million (Q3 2025), and $10.4 billion (Q2 2025).